Conditions: Crohn's Disease
Allocation: RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 24
Healthy volunteers: no

Brief summary:
A randomized, placebo-controlled pilot study to determine endoscopic recurrence of Crohn's disease 12 months after curative, resective ileal or ileocolonic surgery in patients receiving post-operative infliximab or placebo

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: infliximab intervention 2: placebo
Intervention descriptions: intervention 1: 5 mg/kg IV at baseline, 2 weeks, 6 weeks and then every 8 weeks x 6 intervention 2: placebo IV at baseline, 2 weeks, 6 weeks and then every 8 weeks x 6

Protocol document: